All tumor samples (n = 15) showed high expression of transgenic MYC compared to regressing tumors (Fig. 3b) and exhibited at least one of three different mutations (N82T, H100Y, E147K) corresponding to the tetR domain of tTA, consistent with our previous reports22 (Fig. 3c). Here, MYC is linked to neoplasm.